Tamar D. Howson's most recent trade in Immunic Inc was a trade of 25,370 Stock Option done . Disclosure was reported to the exchange on June 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunic Inc | Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2026 | 25,370 | 25,370 | - | - | Stock Option | |
| Immunic Inc | Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 150,000 | 150,000 | - | - | Stock Option | |
| Immunic Inc | Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 100,000 | 100,000 | - | - | Stock Option | |
| Immunic Inc | Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option | |
| Cue Biopharma Inc | Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| MEI Pharma Inc | Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Cue Biopharma Inc | Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |